3
Announcements
Trials
Browse
Landscape
Phase
Phase 4
1
Status
Terminated
1
Sponsor Class
OTHER
1
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Sarcoma
1
Conditions
Pain, Intractable
1
Neoplasms
1
Bone Neoplasms
1
Interventions
Doxorubicin
44
Imatinib Mesylate
33
pembrolizumab
23
Cyclophosphamide
23
Sunitinib
22
Gemcitabine
22
Temozolomide
17
Irinotecan
14
Bevacizumab
14
Docetaxel
13
nilotinib
12
Trabectedin
12
ripretinib
11
pazopanib
11
olaratumab
10
fludarabine
10
eribulin
10
regorafenib
9
avapritinib
9
Fluorouracil
9
Carboplatin
9
Paclitaxel
8
Nivolumab
8
Ifosfamide
8
Ibandronic Acid
8
spartalizumab
7
anlotinib
7
Vincristine
7
Radiation
7
Ipilimumab
7
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
INDUSTRY
×
Pregabalin
×
Sarcoma
×
Clear all
NCT00381095
2021-01-20
COPE
Pfizer
Phase 4
Terminated
152 enrolled
14 charts